Home / GMP & GxP Audits

Independent audits that stand up to scrutiny.

Qualify and monitor suppliers with on-site, remote or hybrid audits that give your Quality Unit objective, evidence-based assurance.

Overview

Audit scope and sectors.

We audit across the pharmaceutical supply chain, scoped around your supplier, products and risk class.

  • Supplier and site qualification audits
  • Pre-inspection and mock inspections
  • QMS and gap audits against ICH Q10 and EU GMP Chapter 1
  • Due diligence audits for acquisitions, partnerships and technology transfer
  • Laboratory and GLP audits
  • Medical device audits to ISO 13485:2016
  • CSV and data integrity audits against Annex 11 and ALCOA+
  • For-cause and follow-up audits after a quality event or CAPA
Auditors reviewing GMP documentation

Sectors

Coverage across the supply chain.

API manufacturers

ICH Q7 and EU GMP Part II audits, including starting materials, impurity control and data integrity.

Excipients and key starting materials

Risk-based audits of supplier quality systems, change control and traceability.

Finished dose manufacturers

Oral solid dose, parenteral and other dosage forms against EU GMP, MHRA and PIC/S expectations.

Packaging and contract sites

Contract manufacturers, packagers and testing partners.

Laboratories

Analytical, microbiology and GLP facilities.

Medical devices

Manufacturers audited to ISO 13485:2016 and the relevant device regulations.

Audit methodology

Assess, audit, report, improve.

Assess: define scope, risk and standards

Every engagement starts with a clear understanding of your supplier, products and the requirements that apply.

  • Scoping call covering supplier, products, risk class, standards, location and audit mode
  • Auditor selected for the site type and scope, with a conflict-of-interest declaration
  • Pre-audit review of questionnaires, site master file, certificates and licences
  • Audit plan agreed with you and the supplier in advance

Auditor expertise

Matched to your supplier.

Each audit is led by an experienced pharmaceutical professional matched to the site type and scope, supported by wider technical expertise where needed.

Audit and consulting are kept separate. We do not assign an auditor to a site where prior involvement could compromise impartiality.

Shared audits and supplier qualification

Where a recent qualifying audit already exists, we manage access to the report in strict confidence, only with the consent of the audited site and report owner. You can also join an audit already planned. Your Quality Unit or QP always makes the final decision on acceptance.

Visit the Audit Library

Regulatory framework

Standards we audit against.

AreaKey references
API GMPICH Q7; EU GMP Part II (EudraLex Volume 4); PIC/S PE 009; MHRA Orange Guide
Quality system and riskICH Q9(R1) and Q10; EU GMP Chapter 1 and Chapter 7
Starting materials, impurities, stabilityICH Q11, Q3A to Q3D, M7, Q1A; EMA and MHRA nitrosamine guidance
Sterile productsEU GMP Annex 1 (2022 revision)
Qualification and validationEU GMP Annex 15
Computerised systems and data integrityEU GMP Annex 11; PIC/S, MHRA and WHO data integrity guidance
Qualified Person and batch certificationDirective 2001/83/EC; EU GMP Annex 16; UK Human Medicines Regulations 2012
DistributionEU Guidelines on GDP (2013/C 343/01); MHRA GDP requirements
LaboratoriesOECD Principles of GLP; UK GLP Regulations 1999; ICH E6 for GCP
Medical devicesISO 13485:2016; EU MDR 2017/745; UK Medical Devices Regulations 2002
Audit practiceISO 19011:2018

FAQ

Frequently asked questions.

What is a third-party GMP audit?

An independent assessment of a supplier, manufacturer, laboratory or service provider, carried out on behalf of a client, against applicable GMP and GxP requirements and the client's quality requirements. It supports supplier qualification, monitoring and risk decisions.

How do you ensure independence?

Every audit follows a documented independence and conflict-of-interest process. Auditors declare any actual, potential or perceived conflict before an engagement, and audit and consulting activities are kept separate.

Do you issue GMP certificates?

No. PharmaTrak does not issue regulatory GMP certificates. We provide independent audit reports and objective evidence that support qualification and compliance decisions.

Is a PharmaTrak audit report acceptable to my QP?

Our report gives your Quality Unit or Qualified Person independent evidence. Acceptance remains their decision and depends on scope, supplier risk and regulatory expectations. Where coverage is insufficient we may recommend a supplementary or focused audit.

Can you conduct remote or hybrid audits?

Yes, where scope and risk assessment show it is appropriate. Some activities need an on-site assessment so that facilities, equipment, utilities and material flows can be observed directly.

How do you protect confidential information?

Through confidentiality agreements, restricted access, controlled document sharing, secure transfer and access limited to authorised personnel. Specific requirements can be agreed per engagement.